Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
This 32-country randomized clinical trial assesses the effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients receiving bempedoic ac